The aim was to determine the intrasession repeatability of swept-source optical coherence tomography (SS-OCT)-derived retinal and choroidal thickness measurements in eyes with neovascular age-related macular degeneration (nAMD). Methods A prospective study consisting of patients with active nAMD enrolled in the Distance of Choroid Study at Moorfields Eye Hospital, London. Patients underwent three 12×9 mm macular raster scans using the deep range imaging (DRI) OCT-1 SS-OCT (Topcon) device in a single imaging session. Retinal and choroidal thicknesses were calculated for the ETDRS macular subfields. Repeatability was calculated according to methods described by Bland and Altman. Results 39 eyes of 39 patients with nAMD were included with a mean (±SD) age of 73.9 (±7.2) years. The mean (±SD) retinal thickness of the central macular subfield was 225.7 μm (±12.4 μm). The repeatability this subfield, expressed as a percentage of the mean central macular subfield thickness, was 23.2%. The percentage repeatability of the other macular subfields ranged from 13.2% to 28.7%. The intrasession coefficient of repeatability of choroidal thickness of the central macular subfield was 57.2 μm with a mean choroidal thickness (±SD) of 181 μm (±15.8 μm). Conclusions This study suggests that a change >23.2% of retinal thickness and 57.2 μm choroidal thickness in the central macular subfield is required to distinguish true clinical change from measurement variability when using the DRI OCT-1 device to manage patients with nAMD.
INTRODUCTION
Swept-source optical coherence tomography (SS-OCT) is a recent development in OCT technology that has been recently introduced into clinical practice. SS-OCT uses a tuneable frequency light source that emits changing light frequencies over time measured by a photometer. 1 This, in combination with line scans averaging that improves the signal-to-noise ratio, leads to faster image acquisition and enhanced visualisation of retinal morphology. The deep range imaging (DRI) OCT-1 (Topcon) incorporates this technology and the use of a long wavelength light source in this device (central wavelength of 1050 nm) theoretically enhances imaging of deeper structures including the choroid. 2 Macular thickness measurements for the various ETDRS subfields are derived using on-board automated segmentation software (Topcon Advanced Boundary Segmentation (TABS)). 3 Changes in macular thickness in eyes with neovascular age-related macular degeneration (nAMD) typically reflect disease activity, and this parameter has therefore become invaluable in guiding anti-angiogenic treatment decisions both in clinical practice and in clinical trials. 4 Variation in the choroid may be associated with a range of macular conditions including pachychoroid and age-related choroidopathy. 5 6 OCT-derived subfoveal choroidal thickness measurements appear to be an important predictive factor in response to treatment with anti-angiogenic agents in eyes with nAMD. [7] [8] [9] It has been suggested that the reported variation in choroidal thickness in patients with nAMD undergoing treatment with antiangiogenic agents indicates a potential role for this parameter in the assessment of disease activity and treatment response. 10 An understanding of the repeatability of OCT-derived macular thickness measurements is important to differentiate true clinical change from mere measurement variability. Definition of measurement repeatability using SS-OCT is essential to fully describe the value of this technology in nAMD. The potential role of SS-OCT visualisation of the choroid in nAMD is being evaluated but the description of thickness repeatability will help clinicians and researchers interpret clinical studies including those with anti-angiogenic agent. SS-OCT repeatability has been reported in normal subjects but there is potential for higher variability in patients with macular disease including nAMD. 11 12 Sources of measurement variability include, but are not limited to, automated inner and outer retinal boundary detection and segmentation errors, which are not uncommon when imaging eyes with nAMD and unstable fixation, resulting in variability in scan placement between consecutive scans. 13 14 This study estimates the repeatability of SS-OCT-derived retinal and choroidal thickness measurements in eyes with nAMD.
MATERIALS AND METHODS
This study analysis forms part of the Distance of Choroid Study. This was a prospective study evaluating the repeatability of a range of modalities imaging the posterior coats of the eye (sclera, choroid and retina). All participants provided written informed consent prior to commencement of the study. The study was approved by the local ethics committee (NRES Committee South East Coast-Surrey) and adhered to the tenet set forth in the Declaration of Helsinki.
Study population
Patients were identified from medical retina clinics at Moorfields Eye Hospital, London, UK. Subjects were eligible if aged between 50 and 90 years and had evidence of subfoveal choroidal neovascularisation (CNV) secondary to nAMD in at least one eye. Lesion size and type were assessed by fundus fluorescein angiography at presentation. If both eyes were eligible, the eye with the worse visual acuity was identified as the study eye. Subjects were required to be able to understand the nature of the study and be willing to undergo all the imaging investigations. Exclusion criteria included other causes of CNV, media opacity precluding an adequate fundus view, previous ocular surgery (other than cataract surgery) and other significant ocular comorbidity in the study eye. Patients with diabetes mellitus were also excluded from this study.
SS-OCT imaging protocol
After informed consent, medical history was obtained and bestcorrected visual acuity (BCVA) was measured. Subjects underwent three consecutive DRI OCT-1 scans in a single imaging session by a clinical trials-certified technician. All subjects were adequately dilated prior to imaging with 1% tropicamide and 2.5% phenylephrine (Chauvin Pharmaceuticals). Each scan consisted of a 12×9 mm raster centred on the fovea. Between scans, patients sat back away from the device and rested for a minimum of 1 min. The device was regularly serviced by a manufacturer-approved engineer.
Analysis of macular retinal and choroidal thickness
Retinal and choroidal thickness measurements of the nine ETDRS macular subfields were calculated using the on-board segmentation algorithm (TABS). The nine macular subfields are of 1 mm (centre A1), 3 mm (inner A2-5) and 6 mm (A6-9) diameter centred on the fovea. The on-board segmentation algorithm defines the inner retinal boundary as the inner limiting membrane and the outer retinal boundary as the outer aspect of the retinal pigment epithelium (RPE)/Bruch's membrane complex. 3 DRI OCT-1 images were directly visualised by an independent observer for automated segmentation error of retinal layers. This was defined as instances in which the software-determined retinal boundaries clearly deviated from true anatomical inner or outer retinal boundaries over a distance of 1 mm or more (figure 1). Patients were excluded if a segmentation error of >1 mm was present in the central macular subfield (A1) in any of the three SS-OCT images taken. 15 Similarly, segmentation error of choroidal layers was defined as instances in which the softwaredetermined choroidal boundaries clearly deviated by 1 mm or more from the true anatomical boundaries (RPE/Bruch's membrane and choroidal-scleral interface) and patients were excluded if this occurred in the central macular subfield in any of the three SS-OCT choroidal images (figure 2). 15 
Statistical analyses
Mean and SD of retinal thickness for each of the nine macular subfields were calculated using Excel (Microsoft Excel for Mac 2011). Repeatability was calculated using methods described by Bland and Altman. 16 Briefly, each variable was confirmed to be normally distributed and the SD of each group of three measurements was plotted against the mean of those measurements to determine whether any variability was even in part related to the magnitude of the measurement (Pearson's correlation coefficient). The intrasubject SD (S w ) was then calculated, and the coefficient of repeatability (CR) was then calculated as 2 Â ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi ð2 Â S w Þ p or 2.77×S w . The width of the 95% CI was calculated as 1:96 Â S w = ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi 2nðm À 1Þ p ; where n is the number of subjects and m is the number of repeated images, as described in previously completed analyses of CR in OCT measurements. 15 These analyses were also performed for choroidal thickness in each of the nine macular ETDRS subfields.
If a significant relationship was found, the data were transformed logarithmically and the analysis was repeated. 17 The intrasubject SD (S w ) of logarithmically transformed data was calculated. The intrasubject coefficient of variation (CV) was calculated as the inverse logarithm of the intrasubject SD minus 1 (CV=Inverse log 10 (S w )−1). The repeatability of the mean retinal thickness measurement of each macular subfield was calculated as 2.77×CV×100%. 18 
RESULTS

Subject characteristics
A total of 39 subjects were included in this study. Subject demographics and other characteristics are detailed in table 1.
Images were obtained between February 2014 and July 2014. The mean (±SD) age of the subjects in the study was 73.9 ±7.2 years. Twenty-four subjects were male and there were 21 right eyes. Mean (±SD) BCVA was 63.9 (±18.5) ETDRS letters. Thirty-seven (94.9%) subjects had undergone treatment with anti-angiogenic agents within the previous 6 months.
Retinal thickness measurements and repeatability
The mean (±SD) retinal thickness of the central macular subfield was 225.7 μm (±12.4 μm). The mean (±SD) retinal thicknesses of the nine macular subfields are shown in table 2. Online supplementary figure S1A shows the relationship between the mean of the three repeated central macular subfield retinal thickness measurements and their SD, and demonstrates a degree of association between mean thickness and variability (Pearson's product moment correlation coefficient r=0.441; p=0.049 two-tailed t-test). Other macular subfields showed a similar degree of association between mean retinal thickness and variability. After logarithmic data transformation, however, there was no statistically significant relationship between mean retinal thickness and SD for any of the macular subfields (central macular subfield: Pearson's product moment correlation coefficient r=0.270; p=0.097 two-tailed t-test) (see online supplementary figure S1B). The percentage repeatability of the central macular subfield was 23.2%. The percentage repeatability of the nine ETDRS macular subfields ranged from 13.2% to 28.7% (table 2) .
Choroidal thickness measurements and repeatability
Mean (±SD) of automated choroidal thickness of each of the nine ETDRS choroidal macular subfields is shown in table 3.
The mean (±SD) choroidal thickness of the central macular subfield was 181 μm (±15.8 μm) . Online supplementary figure S1C shows the relationship between the automated mean choroidal thickness of the central macular subfield and the SD of the measure. No correlation between the size of choroidal thickness measurements and the degree of variation was demonstrated (Pearson's product moment correlation coefficient r=0.038; p=0.820 two-tailed t-test). Plots for the other subfields similarly demonstrated no correlation. The CR of choroidal thickness of the central macular subfield (A1) was 57.2 μm ((95% CI 55.5 to 58.8 μm). The CR of choroidal thickness of the other subfields ranged from 38.5 to 60.3 μm (table 3) .
Automated segmentation error and visual acuity
Manual assessment of all SS-OCT images showed that segmentation error of retinal layers in the central macular subfield in at least one SS-OCT image was present for 9 of 39 eyes (segmentation error rate 23.1%) (figure 1) with a revised CR of 23.0%. Segmentation error of choroidal layers was present in 10 out of 39 eyes (segmentation error rate 25.6%, figure 2 ) with a revised CR of 47.3 μm (45.7-48.1 μm).
Online supplementary figure S2 shows the relationship between visual acuity measurements and the SD of both repeated retina and choroidal thickness metrics of the central macular subfield demonstrating no significant relationship between visual acuity and retinal thickness (Pearson's r=0.05, p=0.75 paired t-test) and choroidal thickness (Pearson's r=−0.09, p=0.59 paired t-test).
DISCUSSION
OCT-derived macular thickness measurements are used to assess disease activity thereby guiding treatment decisions in clinical practice, as well as forming outcome variables in clinical trials that evaluate anti-angiogenic agents for nAMD and other macular disorders.
19-21 SS-OCT has been recently introduced into clinical practice but little is known of the repeatability of SS-OCT-derived macular thickness measurements. Understanding the repeatability of retinal thickness measurements is essential for assessment of disease activity in nAMD. As we discover that changes in choroidal morphology and thickness may be associated with macular disease, it is increasingly important to differentiate between true clinical change and measurement variability. In this study, we determined the percentage repeatability of SS-OCT-derived central subfield retinal thickness to be 23.2%, indicating that changes >23.2% are required to support true clinical activity over simple measurement variability when using the DRI OCT-1 device. Previous studies have evaluated the repeatability of both time-domain-derived and spectral-domain optical coherence tomography (SD-OCT)-derived retinal thickness measurements in nAMD, but to our knowledge, there are no previous reports investigating the repeatability of retinal thickness measurements in eyes with nAMD using a commercially available SS-OCT-based device. [22] [23] [24] After exclusion of patients with segmentation error in at least 1 SS-OCT scan, the revised percentage repeatability of the central macular subfield retinal thickness remained similar to the figure for the whole cohort (23.0%). This relatively modest improvement in repeatability after excluding eyes with segmentation error suggests that segmentation error is not a key factor contributing to measurement variability when using the DRI OCT-1 SS-OCT device to image eyes with nAMD. Evaluation of the images of eyes without segmentation error but which displayed the most significant variability suggests that discrepancies in fixation stability between scans may have been important with some clear variation in ETDRS grid alignment (see online supplementary figure S3 ). This suggests that the addition of eye tracking hardware/software to maintain more precise alignment and registration of follow-up scans could potentially improve repeatability. Several factors have been associated with variation in fixation stability including visual acuity and alteration in macular structure. 25 Reduced visual acuity changes have been particularly associated with poor fixation stability in eyes with nAMD. 26 Intriguingly, there was no significant association between visual acuity and variability of retinal and choroidal thickness measurements in our study and this would suggest that determinants of fixation stability may include factors other than high-contrast distance visual acuity in eyes with nAMD. Evaluation of the clinical significance of SS-OCT-derived choroidal thickness in patients with nAMD requires an appreciation of its measurement variability. Clinicians and researchers may elect to choose this newer technology particularly due to potentially deeper imaging penetration and its reliability in imaging deserve further scrutiny. We report an intrasession CR of the choroidal thickness of the central macular subfield using the DRI OCT-1 SS-OCT device as 57.2 μm (95% CI 55.5 to 58.8 μm). This suggests that a change in central subfield choroidal thickness of more than 57.2 μm is necessary to suggest true clinical change rather than measurement variability in eyes with nAMD. The intrasession CRs of the choroidal thickness of the other macular subfields range from 38.5 to 60.3 μm. To our knowledge, this is the first study reporting repeatability of SS-OCT-derived choroidal thickness measurements in nAMD. Previous studies have reported a higher level of reproducibility of patients when measured manually in healthy patients, including a study at our institution, which suggested a CR of 34 μm using enhanced depth imaging SD-OCT. 27 We note that our previous study investigating SD-OCT (Spectralis, Heidelberg, Heidelberg Engineering) repeatability in AMD reported a CR of 30.6 and 34.7 μm for retinal and choroidal thickness repeatability, respectively. 28 This suggests that SD-OCT may be more repeatable than macular thickness measurements taken in eyes with nAMD using SS-OCT. While it appeared that segmentation error was not a significant factor in SS-OCT measurement repeatability, repeatability of SD-OCT retinal thickness measurements appeared to greatly improve after exclusion of eyes with segmentation error (13.7 μm). This suggests that different factors underlie the variability encountered in nAMD eyes using these different imaging devices. There are several strengths and limitations of this study. This study was prospective in nature, thereby reducing inclusion/ recruitment and reporting biases. Furthermore, the inclusion criteria likely reflected a real-world cohort of patients attending hospital clinics for the treatment of nAMD. This study included three repeated measurements with a large sample size. A potential weakness of this study is that nAMD eyes with scans with segmentation error were not excluded from this study. However, this is likely to reflect real-world data sets where segmentation error is a relatively common occurrence. 14 We attempted to address this potential limitation of the study by also providing a supplementary estimate of the repeatability of the central macular subfield after exclusion of subjects who had at least one SS-OCT scan in which segmentation error occurred. Our analysis however was not corrected for change in fixation between scans and would likely have affected our repeatability estimates adversely. This does however also represent the real-world clinical scenario arguably making our results more generalisable to a clinical setting. Retinal thickness measurements were transformed logarithmically to account for any variation associated with retinal thickness magnitude. It would be useful however to extend this study by assessment of patients with severe macular oedema or atrophic change with disciform scar to assess any possible variation at extremes of macular thickness.
In summary, we report the intrasession percentage repeatability of retinal thickness of the central macular subfield as 23.2% and intrasession CR of choroidal thickness in the central subfield as 57.2 μm using the DRI OCT-1 SS-OCT. This study suggests that a change of >23.2% of retinal thickness and >57.2 μm of choroidal thickness in the central macular subfield is necessary to distinguish true clinical change from measurement variability in nAMD.
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